EQUINE VETERINARY EDUCATION / AE / SEPTEMBER 2017
519
Conclusions
This review summarises the importance of inflammatory and fibrotic processes in the healing of tendon injuries. Preventing the development of chronic inflammation holds the key to promoting improved repair of tendon tissue. It is prudent to treat with a short course of anti-inflammatory drugs in the acute phase after injury. However, prolonged use of COX-2 selective NSAIDs should be avoided in equine cases with tendinopathy.
Author’s declarations of interest No conflicts of interest have been declared.
Ethical animal research Ethical review not applicable for this review article.
Source of funding No funding was obtained for this work.
Acknowledgements
The author’s research fellowship is funded by Arthritis Research UK (grant 20506).
References Buckley, C.D., Pilling, D., Lord, J.M., Akbar, A.N., Scheel-Toellner, D. and Salmon, M. (2001) Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation. Trends Immunol. 22, 199-204.
Campbell, A.L., Smith, N.C., Reilly, J.H., Kerr, S.C., Leach, W.J., Fazzi, U.G., Rooney, B.P., Murrell, G.A. and Millar, N.L. (2014) IL-21 receptor expression in human tendinopathy. Mediators Inflamm. 2014, 481206.
Christensen, B., Dandanell, S., Kjaer, M. and Langberg, H. (2011) Effect of anti-inflammatory medication on the running-induced rise in patella tendon collagen synthesis in humans. J. Appl. Physiol. 110, 137-141.
Crevier-Denoix, N., Collobert, C., Pourcelot, P., Denoix, J.M., Sanaa, M., Geiger, D., Bernard, N., Ribot, X., Bortolussi, C. and Bousseau, B. (1997) Mechanical properties of pathological equine superficial digital flexor tendons. Equine Vet. J. 29, Suppl. 23, 23-26.
Dakin, S.G., Jespers, K., Warner, S., O’Hara, L.K., Dudhia, J., Goodship, A.E., Wilson, A.M. and Smith, R.K. (2011) The relationship between in vivo limb and in vitro tendon mechanics after injury: a potential novel clinical tool for monitoring tendon repair. Equine Vet. J. 43, 418-423.
Dakin, S.G., Dudhia, J., Werling, N.J., Werling, D., Abayasekara, D.R. and Smith, R.K. (2012a) Inflamm-aging and arachadonic acid metabolite differences with stage of tendon disease. PLoS One 7, e48978.
Dakin, S.G., Werling, D., Hibbert, A., Abayasekara, D.R., Young, N.J., Smith, R.K. and Dudhia, J. (2012b) Macrophage sub-populations and the lipoxin A4 receptor implicate active inflammation during equine tendon repair. PLoS One 7, e32333.
Dakin, S.G., Dudhia, J. and Smith, R.K. (2014a) Resolving an inflammatory concept: the importance of inflammation and resolution in tendinopathy. Vet. Immunol. Immunopathol. 158, 121-127.
Dakin, S.G., Smith, R.K., Heinegard, D., Onnerfjord, P., Khabut, A. and Dudhia, J. (2014b) Proteomic analysis of tendon extracellular matrix reveals disease stage-specific fragmentation and differential cleavage of COMP (cartilage oligomeric matrix protein). J. Biol. Chem. 289, 4919-4927.
Dakin, S.G., Martinez, F.O., Yapp, C., Wells, G., Oppermann, U., Dean, B.J., Smith, R.D., Wheway, K., Watkins, B., Roche, L. and Carr, A.J. (2015) Inflammation activation and resolution in human tendon disease. Sci. Transl. Med. 7, 311ra173.
Douglas, M.R., Morrison, K.E., Salmon, M. and Buckley, C.D. (2002) Why does inflammation persist: a dominant role for the stromal microenvironment?. Expert Rev. Mol. Med. 4, 1-18.
Dudhia, J., Scott, C.M., Draper, E.R., Heinegard, D., Pitsillides, A.A. and Smith, R.K. (2007) Aging enhances a mechanically-induced reduction in tendon strength by an active process involving matrix metalloproteinase activity. Aging Cell 6, 547-556.
Franceschi, C., Bonafe, M., Valensin, S., Olivieri, F., De Luca, M., Ottaviani, E. and De Benedictis, G. (2000) Inflamm-aging. An evolutionary perspective on immunosenescence. Ann. N. Y. Acad. Sci. 908, 244-254.
Gilroy, D.W., Colville-Nash, P.R., Willis, D., Chivers, J., Paul-Clark, M.J. and Willoughby, D.A. (1999) Inducible cyclooxygenase may have anti-inflammatory properties. Nat. Med. 5, 698-701.
Gilroy, D.W., Lawrence, T., Perretti, M. and Rossi, A.G. (2004) Inflammatory resolution: new opportunities for drug discovery. Nat. Rev. Drug Discov. 3, 401-416.
Jarvinen, T.A., Kannus, P., Maffulli, N. and Khan, K.M. (2005) Achilles tendon disorders: etiology and epidemiology. Foot Ankle Clin. 10, 255-266.
Kragsnaes, M.S., Fredberg, U., Stribolt, K., Kjaer, S.G., Bendix, K. and Ellingsen, T. (2014) Stereological quantification of immune- competent cells in baseline biopsy specimens from achilles tendons: results from patients with chronic tendinopathy followed for more than 4 years. Am. J. Sports Med. 42, 2435-2445.
Lawrence, T. and Gilroy, D.W. (2007) Chronic inflammation: a failure of resolution? Int. J. Exp. Pathol. 88, 85-94.
Levy, B.D., Clish, C.B., Schmidt, B., Gronert, K. and Serhan, C.N. (2001) Lipid mediator class switching during acute inflammation: signals in resolution. Nat. Immunol. 2, 612-619.
Levy, B.D., Lukacs, N.W., Berlin, A.A., Schmidt, B., Guilford, W.J., Serhan, C.N. and Parkinson, J.F. (2007) Lipoxin A4 stable analogs reduce allergic airway responses via mechanisms distinct from CysLT1 receptor antagonism. FASEB J. 21, 3877-3884.
Li, M.O., Wan, Y.Y., Sanjabi, S., Robertson, A.K. and Flavell, R.A. (2006) Transforming growth factor-beta regulation of immune responses. Annu. Rev. Immunol. 24, 99-146.
Lucas, T., Waisman, A., Ranjan, R., Roes, J., Krieg, T., Muller, W., Roers, A. and Eming, S.A. (2010) Differential roles of macrophages in diverse phases of skin repair. J. Immunol. 184, 3964-3977.
Martinez, F.O. and Gordon, S. (2014) The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Reports, 6, 13.
Millar, N.L., Wei, A.Q., Molloy, T.J., Bonar, F. and Murrell, G.A. (2009) Cytokines and apoptosis in supraspinatus tendinopathy. J. Bone Joint Surg. Br. 91, 417-424.
Millar, N.L., Hueber, A.J., Reilly, J.H., Xu, Y., Fazzi, U.G., Murrell, G.A. and McInnes, I.B. (2010) Inflammation is present in early human tendinopathy. Am. J. Sports Med. 38, 2085-2091.
Morris, T., Stables, M., Hobbs, A., de Souza, P., Colville-Nash, P., Warner, T., Newson, J., Bellingan, G. and Gilroy, D.W. (2009) Effects of low- dose aspirin on acute inflammatory responses in humans. J. Immunol. 183, 2089-2096.
Murray, P.J., Allen, J.E., Biswas, S.K., Fisher, E.A., Gilroy, D.W., Goerdt, S., Gordon, S., Hamilton, J.A., Ivashkiv, L.B., Lawrence, T., Locati, M., Mantovani, A., Martinez, F.O., Mege, J.L., Mosser, D.M., Natoli, G., Saeij, J.P., Schultze, J.L., Shirey, K.A., Sica, A., Suttles, J., Udalova, I., van Ginderachter, J.A., Vogel, S.N. and Wynn, T.A. (2014) Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity 41, 14-20.
Ortega-Gomez, A., Perretti, M. and Soehnlein, O. (2013) Resolution of inflammation: an integrated view. EMBO Mol. Med. 5, 661-674.
Parsons, C.J., Takashima, M. and Rippe, R.A. (2007) Molecular mechanisms of hepatic fibrogenesis. J. Gastroenterol. Hepatol. 22, Suppl. 1, S79-S84.
© 2016 EVJ Ltd
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88
